Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia

European Urology, Supplements

Volumn 8, Issue 6, 2009, Pages 513-522

  Tzortzis, Vassilios ^a   Gravas, Stavros ^a   de la Rosette, Jean J M C H ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Benign prostatic hyperplasia; Holmium laser enucleation of the prostate (HoLEP); Laser prostatectomy; Potassium titanyl phosphate (KTP); Transurethral microwave thermotherapy (TUMT); Transurethral needle ablation (TUNA)

Indexed keywords

CLINICAL TRIAL; HOLMIUM LASER; HUMAN; INTERMETHOD COMPARISON; LASER PROSTATECTOMY; LOCAL ANESTHESIA; LOWER URINARY TRACT SYMPTOM; MEDICAL TECHNOLOGY; MINIMALLY INVASIVE SURGERY; MORBIDITY; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; RISK ASSESSMENT; SURGICAL RISK; SYSTEMATIC REVIEW; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL NEEDLE ABLATION; TRANSURETHRAL RESECTION;

EID: 60449086051     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2009.02.004     Document Type: Review

References (54)

1. Rassweiler J., Teber D., Kuntz R., and Hofmann R. Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 50 (2006) 969-980
2. Roos N.P., Wennberg J.E., Malenka D.J., et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 320 (1989) 1120-1124
3. de la Rosette JJMCH, Gravas S., Muschter R., et al. Present practice and development of minimally invasive techniques, imaging and training in European urology: results of a survey of the European Society of Uro-Technology (ESUT). Eur Urol 44 (2003) 346-351
4. Yu X., Elliott S.P., Wilt T.J., and McBean A.M. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol 180 (2008) 241-245
5. Brehmer M., Hilliges M., and Kinn A.C. Denervation of periurethral prostatic tissue by transurethral microwave thermotherapy. Scand J Urol Nephrol 34 (2000) 42-52
6. Brehmer M., and Svensson I. Heat-induced apoptosis in human prostatic stromal cells. BJU Int 85 (2000) 535-541
7. Bolmsjo M., Wagrell L., Hallin A., Eliasson T., Erlandsson B.E., and Mattiasson A. The heat is on-but how? A comparison of TUMT devices. Br J Urol 78 (1996) 564-572
8. Walmsley K., and Kaplan S. Transurethral microwave thermotherapy for benign prostatic hyperplasia: separating truth from marketing hype. J Urol 172 (2004) 1249-1255
9. Hoffman RM, Monga M, Elliot S, et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev 2007; 17:CD004135.
10. Kaye J.D., Smith A.D., Badlani G.H., Lee B.R., and Ost M.C. High-energy transurethral thermotherapy with CoreTherm approaches transurethral prostate resection in outcome efficacy: a meta-analysis. J Endourol 22 (2008) 713-718
11. Gravas S., Laguna P., Ehrnebo M., Wagrell L., Mattiasson A., and de la Rosette JJMC.H. Seeking for evidence that cell kill guided thermotherapy gives results not inferior to transurethral resection of prostate: results of a pooled analysis of 3 studies on feedback transurethral microwave thermotherapy. J Urol 174 (2005) 1002-1006
12. Schelin S. Microwave thermotherapy in patients with benign prostatic hyperplasia and chronic urinary retention. Eur Urol 39 (2001) 400-404
13. Kellner D.S., Armenakas N.A., Brodherson M., Heyman J., and Fracchia J.A. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia. Urology 64 (2004) 703-706
14. Djavan B., Roehrborn C.G., Shariat S., Ghawidel K., and Marberger M. Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia. J Urol 161 (1999) 139-143
15. Djavan B., Seitz C., Roehrborn C.G., et al. Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months. Urology 57 (2001) 66-70
16. de la Rosette JJMCH, Laguna M.P., Gravas S., and de Wildt M.J.A.M. Transurethral microwave thermotherapy: the gold standard for minimally invasive therapies or patients with benign prostatic hyperplasia?. J Endourol 17 (2003) 245-251
17. Barmoshe S., and Zlotta A.Z. How do I treat and follow my TUNA patients. World J Urol 24 (2006) 397-404
18. Boyle P., Robertson C., Vaughan E.D., and Fitzpatrick J.M. A meta-analysis of trials of trnasurethral needle ablation for treating symptomatic benign prostatic obstruction. BJU Int 94 (2004) 83-88
19. Bouza C., López T., Magro A., Navalpotro L., and Amate J.M. Systematic review and meta-analysis of transurethral needle ablation in symptomatic benign prostatic hyperplasia. BMC Urol 6 (2006) 14
20. Bruskewitz R., Issa M.M., Roehrborn C.G., et al. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 159 (1998) 1588-1593
21. Roehrborn C.G., Burkhard F.C., Bruskewitz R.C., et al. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study. J Urol 162 (1999) 92-97
22. Hill B., Bel Ville W., Bruskewitz R., et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic obstruction: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 171 (2004) 2336-2340
23. Schulman C.C., and Zlotta A.R. Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: early clinical experience. Urology 45 (1995) 28-33
24. Steele G.S., and Sleep D.J. Transurethral needle ablation of the prostate: a urodynamic based study with 2-year follow-up. J Urol 158 (1997) 1834-1838
25. Kuntz R.M. Laser treatment of benign prostatic hyperplasia. World J Urol 25 (2007) 241-247
26. Tan A.H., and Gilling P.J. Lasers in the treatment of benign prostatic hyperplasia: an update. Curr Opin Urol 15 (2005) 55-58
27. Gilling P.J. Holmium laser enucleation of the prostate (HoLEP). BJU Int 101 (2008) 131-142
28. Kuntz R.M., and Lehrich K. Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm: a randomized prospective trial of 120 patients. J Urol 168 (2002) 1465-1469
29. Elzayat E.A., and Elhilali M.M. Holmium laser enucleation of the prostate (HoLEP): the endourologic alternative to open prostatectomy. Eur Urol 49 (2006) 87-91
30. Gilling P.J., Kennett K., Westenberg A.M., et al. Relief of symptoms and obstruction following HoLEP and TURP-size matters: a meta-analysis. J Endourol 19 Suppl 1 (2005) MP24-14, A119
31. Tan A., Liao C., Mo Z., and Cao Y. Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg 94 (2007) 1201-1208
32. Lourenco T., Pickard R., Vale L., et al. Benign Prostatic Enlargement Team. Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials. BMJ 337 (2008) a1662
33. Naspro R., Suardi N., Salonia A., et al. Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 50 (2006) 563-568
34. Kuntz R.M., Lehrich K., and Ahyai S.A. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 53 (2008) 160-168
35. Elzayat E.A., and Elhilali M.M. Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. Eur Urol 52 (2007) 1465-1472
36. Gilling P.J., Aho T.F., Frampton C.M., et al. Holmium laser enucleation of the prostate: results at 6 years. Eur Urol 53 (2008) 744-749
37. Vavassori I., Valenti S., Naspro R., et al. Three-year outcome following holmium laser enucleation of the prostate combined with mechanical morcellation in 330 consecutive patients. Eur Urol 53 (2008) 599-606
38. Lee R., Gonzalez R.R., and Te A.E. The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia. World J Urol 24 (2006) 405-409
39. Malek R.S., Barrett D.M., and Kuntzman R.S. High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 51 (1998) 254-256
40. Malek R.S., Kuntzman R.S., and Barrett D.M. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol 163 (2000) 1730-1733
41. Hai M.A., and Malek R.S. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 17 (2003) 93-96
42. Bouchier-Hayes D.M., Anderson P., van Appledorn S., et al. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 20 (2006) 580-585
43. Bouchier-Hayes D.M. Photoselective vaporization of the prostate-towards a new standard. Prostate Cancer Prostatic Dis 10 Suppl 1 (2007) S10-S14
44. Horasanli K., Silay M.S., Altay B., Tanriverdi O., Sarica K., and Miroglu C. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology 71 (2008) 247-251
45. Alivizatos G., Skolarikos A., Chalikopoulos D., et al. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80 ml: 12-mo results of a randomized prospective study. Eur Urol 54 (2008) 427-437
46. Skolarikos A., Papachristou C., Athanasiadis G., Chalikopoulos D., Deliveliotis C., and Alivizatos G. Eighteen-month results of a randomized prospective study comparing transurethral photoselective vaporization with transvesical open enucleation for prostatic adenomas greater than 80 cc. J Endourol 22 (2008) 2333-2340
47. Malek R., Kuntzman R., and Barrett D.M. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 174 (2005) 1344-1348
48. Te A.E., Malloy T.R., Stein B.S., Ulchaker J.C., Nseyo U.O., and Hai M.A. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 97 (2006) 1229-1233
49. Ruszat R., Seitz M., Wyler S.F., et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 54 (2008) 893-901
50. Lee R., Saini R., Zoltan E., and Te A.E. Photoselective vaporization of the prostate using a laser high performance system in the canine model. J Urol 180 (2008) 1551-1553
51. Muir G., Gómez Sancha F., Bachmann A., et al. Techniques and training with GreenLight HPS 120-W laser therapy of the prostate: position paper. Eur Urol Suppl 7 (2008) 370-377
52. Spaliviero M., Araki M., and Wong C. Short-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). J Endourol 22 (2008) 2341-2347
53. de la Rosette JJMCH, Alivizatos G, Madersbacher S, et al. Guidelines on Benign Prostatic Hyperplasia. Arnhem, the Netherlands: European Association of Urology; 2008. http://www.uroweb.org/fileadmin/tx_eauguidelines/BPH.pdf.
54. Baba S., Badlani G., Elhilali M., et al. New minimally invasive and surgical developments in the management of BPO. In: Mc Connell J., Abrams P., Akaza H., and Roerborn C. (Eds). 6th International Consultation on New Developments in Prostate Cancer and Prostate Diseases (2006), Health Publications, Paris, France